Humor and Quirks Humor and Quirks

Robyn Karnauskas Initiated (BIIB) at Strong Buy and Held Target at $360 on, Sep 20th, 2017


Published on 2024-10-25 22:55:46 - WOPRAI, Robyn Karnauskas
  Print publication without navigation


Robyn Karnauskas of SunTrust Robinson Humphrey, Initiated "Biogen Inc." (BIIB) at Strong Buy and Held Target at $360 on, Sep 20th, 2017.

Robyn has made no other calls on BIIB in the last 4 months.



There are 7 other peers that have a rating on BIIB. Out of the 7 peers that are also analyzing BIIB, 5 agree with Robyn's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Brian Abrahams of "RBC Capital" Initiated at Hold and Held Target at $319 on, Friday, September 15th, 2017
  • Jeffrey Silber of "BMO Capital" Maintained at Hold with Increased Target to $377 on, Wednesday, September 13th, 2017
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $311 on, Wednesday, July 26th, 2017
  • Carter Gould of "UBS" Maintained at Hold with Increased Target to $285 on, Wednesday, July 26th, 2017
  • Eun Yang of "Jefferies" Initiated at Hold and Held Target at $310 on, Tuesday, July 11th, 2017


These are the ratings of the 2 analyists that currently disagree with Robyn


  • Terence Flynn of "Goldman Sachs" Upgraded at Strong Buy on, Wednesday, August 16th, 2017
  • Andrew Peters of "Deutsche Bank" Initiated at Strong Buy and Held Target at $315 on, Friday, June 23rd, 2017